Medtronic strengthens its Acute Care & Monitoring wearables portfolio in the U.S. with a new distribution agreement for the Corsano™* multi-parameter wearable

Medtronic, a key player in healthcare technology, has unveiled the expansion of its strategic alliance with Corsano Health B.V., an innovative MedTech company specializing in modern real-time remote patient monitoring solutions. This agreement covers exclusive distribution of Corsano Health's cutting-edge wearable solution in the U.S. for hospital & hospital-to-home use, with a wrist worn form factor to its remote patient monitoring portfolio.

Kate Benedict, president of the Acute Care and Monitoring business, commented that upon the success with the Corsano™* multi-parameter wearable across multiple application cases across Europe, like utilization in stable patients in the emergency department, pre-operative care, medical surgical units, & cardiac care areas, with monitoring fostering patients along their care pathways, from pre-surgery to in-hospital recovery & into the home. They are pleased to introduce this innovative monitoring solution to the U.S. market.

About Corsano Health

This is a major MedTech company that evolves, manufactures, and sells advanced real-time remote patient monitoring solutions.

About Medtronic

It is headquartered in Galway, Ireland, and is a prominent global healthcare technology company that actively targets the most restricting health problems facing humanity by searching out and determining solutions.

According to Towards Healthcare, the U.S. acute care telemedicine market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 15.18 billion in 2026 to approximately USD 54.54 billion by 2035, representing a compound annual growth rate (CAGR) of 15.27% from 2026 to 2035. The market progression is mainly fueled by a massive rise in adoption of virtual care, severe physician shortages, & expanding ageing population. The execution of these kinds of solutions allows remote emergency consultations, ICU monitoring, & specialist access by lowering hospital readmissions & operational expenditures.

Prospective Advances in HaH & AI Diagnostics

According to Towards Healthcare, the U.S. acute care telemedicine market will promote Hospital at Home (HaH) models, which unite video consultations, Remote Patient Monitoring (RPM), & in-person nursing. Alongside, enables health systems to safely treat acute infectious and chronic illnesses outside of physical inpatient wards, improving costs & reducing mortality risks. AI & virtual diagnostics will also have a pivotal role in the future, which will support faster diagnostic triage, estimate patient deterioration earlier than human observation, and simplify virtual clinical workflows.